TuHURA Biosciences, Inc. HURA Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by TuHURA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about TuHURA Biosciences, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TuHURA Biosciences, Inc.'s additional paid-in capital?
- TuHURA Biosciences, Inc. (HURA) reported additional paid-in capital of $171.57M in Q1 2026.
- How has TuHURA Biosciences, Inc.'s additional paid-in capital changed year-over-year?
- TuHURA Biosciences, Inc.'s additional paid-in capital increased by 31.6% year-over-year, from $130.38M to $171.57M.
- What is the long-term trend for TuHURA Biosciences, Inc.'s additional paid-in capital?
- Over 3 years (2022 to 2025), TuHURA Biosciences, Inc.'s additional paid-in capital has grown at a 4.8% compound annual growth rate (CAGR), from $140.57M to $161.78M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.